{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

Rockland Reports on First 2 Drill Holes Completed at the Cole Gold Mines Project in the Red Lake District, Ontario

February 6, 2026VANCOUVER, BC - February 6, 2026 (NEWMEDIAWIRE) - Rockland Resources Ltd. (the “Company” or "Rockland") (CSE: RKL) (OTCQB: BERLF) (FSE: GB2) is pleased to report it has obtained visible gold in the first 2 drill holes completed, of an ongoing 3,000-metre diamond drilling program at its 100%-owned Cole Gold Mines Project, located in the prolific Red Lake Mining District of Ontario.


Blue Lagoon Marks One-Year Anniversary of Mining Permit Receipt as Gold & Silver Price Outlook Strengthens and Operational Milestones Accelerate

February 6, 2026VANCOUVER, BC - February 6, 2026 (NEWMEDIAWIRE) - Blue Lagoon Resources Inc. (CSE: BLLG; OTCQB: BLAGF; FSE: 7BL) today marked the one-year anniversary of receiving its mining permit for the Company’s 100%-owned Dome Mountain Gold and Silver Project in British Columbia - an achievement shared by only nine mining projects permitted in the province over the past decade.


HKTDC to Host World's Largest One-stop Jewellery Marketplace

February 5, 2026New Hard Pure Gold Pavilion Showcases Breakthrough Gold Technologies HONG KONG - February 5, 2026 (NEWMEDIAWIRE) - Organised by the Hong Kong Trade Development Council (HKTDC), the world’s largest one-stop jewellery marketplace will return in early March under its proven “Two Shows, Two Venues” format. The 12th Hong Kong International Diamond, Gem & Pearl Show will take place from 2 to 6 March at AsiaWorld-Expo and will feature a wide range of jewellery raw materials.


Helix Biopharma Corp. Extends LEUMUNA Option With metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases

February 5, 2026TORONTO, ONTARIO - February 5, 2026 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: “HBP”, OTC PINK: “HBPCD”, FRANKFURT: “HBP0”) (“Helix” or the “Company”), a clinical-stage oncology company shaping a near future where today’s hard-to-treat cancers are vincible, today announced the extension of its Research and Exclusive Option Agreement (the “Agreement”) with metaShape Pharma AG (“metaShape”) covering LEUMUNA™ through December 31, 2028.


Datavault AI (DVLT) Issues Stockholder Letter Highlighting 2025 Milestones, 2026 Expansion Outlook

February 5, 2026LOS ANGELES, CA - February 5, 2026 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT) announced the release of a letter from Chief Executive Officer Nathaniel Bradley to stockholders outlining the company’s accomplishments in 2025 and its strategic priorities for 2026, including expanded national infrastructure rollouts, commercialization of data monetization and tokenization platforms, and scaling secure edge-node deployments across more than 100 U. S.


New Medication May Reduce Chances of a Second Clot-Caused Stroke Without Bleeding Risk

February 5, 2026Research Highlights: When added to standard blood-thinning medications such as aspirin, the new anti-clotting medication asundexian reduced the risk of a second stroke by reducing the formation of blood clots without increasing the risk of bleeding. This is the first completed trial of a Factor XI inhibitor investigating whether the medication asundexian is better than standard therapy at safely preventing recurrent strokes.


Focus Universal Announces Reverse Stock Split

February 5, 2026ONTARIO, CA - February 5, 2026 (NEWMEDIAWIRE) - Focus Universal Inc. (Nasdaq: FCUV) (“Focus” or the “Company”), a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G, announces that its Board of Directors has approved a 1-for-10 reverse stock split of the Company’s common stock (the “Reverse Split”).


Lexaria Announces Positive Final Results From Human Pilot Study #5

February 5, 2026Company Further Examining the Pursuit of the World’s First Oral Liraglutide Product KELOWNA, BRITISH COLUMBIA - February 5, 2026 (NEWMEDIAWIRE) - Lexaria Bioscience Corp. (Nasdaq: LEXX), (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce final results from Human Pilot Study #5 (GLP-1-H25-5) (the “Study”) which compared oral DehydraTECH-liraglutide (“DHT-LIR”) capsules to injected Saxenda® branded liraglutide (“SAX-LIR”).